Regeneron Pharmaceuticals, Inc. (REGN)
782.47
-10.79
(-1.36%)
USD |
NASDAQ |
Sep 11, 13:46
Regeneron Pharmaceuticals Gross Profit (TTM) : 12.65B for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 12.65B |
| March 31, 2026 | 12.07B |
| December 31, 2025 | 11.70B |
| September 30, 2025 | 11.64B |
| June 30, 2025 | 11.65B |
| March 31, 2025 | 11.59B |
| December 31, 2024 | 11.75B |
| September 30, 2024 | 11.46B |
| June 30, 2024 | 11.17B |
| March 31, 2024 | 10.87B |
| December 31, 2023 | 10.88B |
| September 30, 2023 | 10.98B |
| June 30, 2023 | 10.69B |
| March 31, 2023 | 10.52B |
| December 31, 2022 | 10.40B |
| September 30, 2022 | 11.39B |
| June 30, 2022 | 11.79B |
| March 31, 2022 | 13.68B |
| December 31, 2021 | 13.35B |
| September 30, 2021 | 11.46B |
| June 30, 2021 | 10.50B |
| March 31, 2021 | 7.740B |
| December 31, 2020 | 7.141B |
| September 30, 2020 | 6.721B |
| June 30, 2020 | 6.225B |
| Date | Value |
|---|---|
| March 31, 2020 | 5.988B |
| December 31, 2019 | 5.582B |
| September 30, 2019 | 5.763B |
| June 30, 2019 | 5.815B |
| March 31, 2019 | 5.918B |
| December 31, 2018 | 6.128B |
| September 30, 2018 | 5.803B |
| June 30, 2018 | 5.644B |
| March 31, 2018 | 5.493B |
| December 31, 2017 | 5.330B |
| September 30, 2017 | 5.011B |
| June 30, 2017 | 4.800B |
| March 31, 2017 | 4.587B |
| December 31, 2016 | 4.456B |
| September 30, 2016 | 4.297B |
| June 30, 2016 | 4.157B |
| March 31, 2016 | 3.933B |
| December 31, 2015 | 3.636B |
| September 30, 2015 | 3.400B |
| June 30, 2015 | 3.049B |
| March 31, 2015 | 2.761B |
| December 31, 2014 | 2.562B |
| September 30, 2014 | 2.384B |
| June 30, 2014 | 2.276B |
| March 31, 2014 | 2.078B |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 3.827B |
| AbbVie, Inc. | 45.98B |
| Gilead Sciences, Inc. | 24.33B |
| Amgen, Inc. | 27.78B |
| Biogen, Inc. | 6.211B |